Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2017-08-17 2017-07-21
Drug Identification Number 02248416 02248416
Brand name FASTURTEC FASTURTEC
Common or Proper name Fasturtec 1.5mg vial powder plus 1.0mL solvent Fasturtec 1.5mg vial powder plus 1.0mL solvent
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients RASBURICASE RASBURICASE
Strength(s) 1.5MG 1.5MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3 vials 3 vials
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2017-07-17 2017-07-17
Estimated end date 2017-09-04 2017-09-04
Actual end date 2017-08-16
Shortage status Resolved Actual shortage
Company comments RESOLVED/RELEASED 2017-08-16 Supply delay with the manufacturing facility
Health Canada comments